Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | ANTHEM Anthem Biosciences Limited Pharma · Large | GLAXO GlaxoSmithKline Pharmaceuticals Limited Pharma · Large | AJANTPHARM Ajanta Pharma Limited Pharma · Large | IPCALAB IPCA Laboratories Limited Pharma · Large |
|---|---|---|---|---|
| Final Score | 51 | 60 | 54 | 43 |
| Verdict | FAIR VALUE | UNDERVALUED | FAIR VALUE | WATCHLIST |
| Style | Premium Compounder | Premium Compounder | Premium Compounder | WATCHLIST |
| Piotroski | 8/9 | 8/9 | 8/9 | 8/9 |
| Valuation | 0/30 | 4/30 | 4/30 | 0/30 |
| Growth | 14/25 | 11/25 | 13/25 | 10/25 |
| Quality | 17/20 | 20/20 | 17/20 | 12/20 |
| Balance Sheet | 11/15 | 12/15 | 11/15 | 9/15 |
| Cash Flow | 4/10 | 7/10 | 4/10 | 8/10 |
| Price | ₹775 | ₹2,194.7 | ₹3,017.2 | ₹1,635 |
| P/E | 71.40 | 36.20 | 35.10 | 34.80 |
| P/B | 14.26 | 16.30 | 8.20 | 5.19 |
| ROE | 22.30% | 48.40% | 25.40% | 16.00% |
| ROCE | 30.40% | 65.10% | 32.30% | 17.30% |
| Debt / Equity | 0.02 | 0.02 | 0.06 | 0.10 |
| FCF Yield | 0.33% | 3.51% | 0.27% | 2.14% |
| Dividend Y | 0.26% | 2.61% | 0.94% | 0.24% |
| Altman Z | 8.94 | 8.62 | 8.92 | 8.21 |
| Promoter % | 74.67% | 75.00% | 66.25% | 44.72% |
| Mkt Cap (₹Cr) | 43515.00 | 36995.00 | 37091.00 | 41817.00 |
| Graham # | ₹113.37 | ₹429.38 | ₹829.71 | ₹567.3 |
| Fair PE | 42.0 | 42.0 | 42.3 | 8.7 |
| MoS % | -75.1% | +14.6% | +15.6% | -317.3% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startANTHEM103
GLAXO86
AJANTPHARM105
IPCALAB105